Armstrong A L, Wallace W A
Department of Orthopaedic and Accident Surgery, University Hospital, Notingham, United Kingdom.
Acta Orthop Belg. 1994;60 Suppl 1:85-101.
Hip fractures are common in the elderly, affecting 1 in 4 women by the age of 90 years and 1 in 8 men. These fractures have caused an "epidemic" during the last 20 years because the age specific rate for such fractures has doubled, and there has been a significant increase in the size of the elderly population in Europe. Hip fracture patients occupy a quarter of all orthopedic beds, the treatment is costly and the rehabilitation slow. Fifteen percent die in hospital; 33% are dead by one year. Of survivors only 2/3 return to their own home. There is now a move to prevent such fractures. Hip fractures arise in the elderly for two reasons: deteriorating bone stock and increasing falls. Hip fracture prevention needs to address both issues, but most work has looked at bone stock. Predictions of hip fracture risk even if based on bone density are poor, so preventive measures need to target the whole population. Bone density rises to a peak at 35 to 40 years in both sexes; men have a higher bone density at all times than women. Thereafter there is a steady loss of 1-2% per year. Women have 10 years of accelerated loss after the menopause. Hip fracture prevention starts by ensuring that peak bone mass is reached. This is under genetic influence but may be maximized by adequate dietary calcium and physical activity in adolescence. Smoking, alcohol and steroid use reduce bone density and their use should be moderated. In women amenorrhea reduces bone density. For women, estrogen may stop menopausal loss and maintain bone density for at least 15 years and in retrospective studies can reduce the fracture risk by 50%. Calcitonin may be an alternative. Five years beyond the menopause primary or secondary prevention may be started. Estrogen is still the best therapy but may be less popular because of the return of menstrual periods. Calcitonin or oral calcium supplements may also be of benefit. Drugs in combination may be more effective than alone. Over age 70, when calcium absorption diminishes, vitamin D, calcium and calcitonin may be effective. For men, treatment options are calcium, calcitonin or, later on, vitamin D. The role of exercise in bone density protection is unclear but should be encouraged for general health reasons. Bisphosphonates are new drugs that may be useful. Falls become increasingly common in the elderly such that up to 80% of all 80-year-olds may sustain at least one fall per year.(ABSTRACT TRUNCATED AT 400 WORDS)
髋部骨折在老年人中很常见,90岁时每4名女性中就有1人受影响,每8名男性中就有1人受影响。在过去20年里,这类骨折引发了一场“流行病”,因为此类骨折的年龄别发病率翻了一番,而且欧洲老年人口规模大幅增加。髋部骨折患者占所有骨科病床的四分之一,治疗成本高昂,康复缓慢。15%的患者在医院死亡;一年后33%的患者死亡。幸存者中只有三分之二能回到自己家中。现在正采取行动预防此类骨折。老年人发生髋部骨折有两个原因:骨量下降和跌倒增加。预防髋部骨折需要解决这两个问题,但大多数工作都着眼于骨量。即使基于骨密度对髋部骨折风险进行预测,效果也很差,因此预防措施需要针对全体人群。男女骨密度在35至40岁时达到峰值;男性在任何时候的骨密度都高于女性。此后,每年稳定流失1%至2%。女性在绝经后有10年骨量加速流失期。预防髋部骨折首先要确保达到峰值骨量。这受遗传影响,但在青春期通过充足的膳食钙和体育活动可使其最大化。吸烟、饮酒和使用类固醇会降低骨密度,应适度使用。对女性而言,闭经会降低骨密度。对女性来说,雌激素可阻止绝经后的骨量流失并维持骨密度至少15年,回顾性研究表明其可将骨折风险降低50%。降钙素可能是一种替代选择。绝经后5年可开始一级或二级预防。雌激素仍是最佳疗法,但可能因月经复潮而不太受欢迎。降钙素或口服钙补充剂可能也有益处。联合用药可能比单独用药更有效。70岁以上时,钙吸收减少,维生素D、钙和降钙素可能有效。对男性来说,治疗选择是钙、降钙素,或者稍后使用维生素D。运动在保护骨密度方面的作用尚不清楚,但出于总体健康原因应予以鼓励。双膦酸盐是可能有用的新药。跌倒在老年人中越来越常见,以至于所有80岁老人中高达80%的人每年可能至少跌倒一次。(摘要截选至400词)